Introduction
In situ gene analyses provide information about tissue-/cellspecific and subcellular gene expression at different embryonic developmental stages and about cells within normal and diseased tissue; some of these methods have been applied to prenatal diagnoses and tumor characterization.
The first in situ hybridizations to visualize target gene transcripts were performed in 1969 using a radioisotope probe. 1 The detection techniques currently used rely on fluorescence imaging; for instance, fluorescence in situ hybridization (FISH) 2 is a method that is widely used in the clinical field. Other similar detection techniques, such as, RNA scope 3 and in situ padlock probe/ rolling circle amplification (padlock/RCA) 4 ,5 have also been described.
The in situ padlock/RCA method is sensitive enough to detect a single DNA molecule and can discriminate DNA at singlebase resolution, and has excellent performance in terms of DNA quantification. 6 Padlock probes are linear oligonucleotides that can detect target sequences that are complementary at both ends. 7, 8 In the presence of the target, the padlock probe circularizes via DNA ligation and acts as a template for RCA, which generates a long single-stranded DNA molecule; a probe conjugated with a fluorescent label can be visualized as a 1-μm-sized dot under a fluorescence microscope. This technique has been applied to the detection of specific point mutations in the mitochondrial genome of individual cells, 4 replication of porcine circovirus type 2 in cultured cells and infected tissues, 9 mRNA expression within a cell in combination with a reverse transcription reaction, 5,10 mRNA sequencing, 11 and protein localization in combination with an antigen-antibody reaction, also known as proximity ligation assay. 12 Although useful, in situ padlock/RCA has the drawback of being a labor-intensive, costly procedure. While real-time PCR 13 and loop-mediated isothermal amplification 14 combine several reactions in a single solution, in situ padlock/RCA requires more than 13 solution changes. The cost of reagents, including for the DNA probes used with in situ methods, is very high (approximately $90 per slide 15 ). Therefore, a desirable objective is to reduce the size and consequently the cost of the reaction.
FISH performed in a microfluidic device can potentially reduce reagent volumes and is thought to be effective; however, there have been few studies to date that have used this approach. [15] [16] [17] [18] [19] Microfluidic-based analyses require 0.5 to 1 μL of probe solution, as compared to the 10 μL required for conventional FISH; this reduces the cost by 90 -95%. 15, 17 In one study of first metaphase chromosomes in which the X-chromosome in a peripheral blood lymphocyte was detected by FISH, the consumed reagent volume was only 14 mL using the microfluidic device, as compared to 327 mL required in traditional FISH analysis. 18 Sequential injections with the microdevice also facilitated the procedure. 17 There have been a few reports on the integration of padlock/ RCA with a microdevice [20] [21] [22] [23] extracted DNA solution was used as the sample. [20] [21] [22] In our previous study, a 60-μm deep microchannel was filled with DNA-modified microbeads to trap sample DNA, which was subjected to solid-phase padlock/RCA 21 ; 30 amol Salmonella genomic DNA was detected using this system, which reduced sample volumes to 5 nL for a 100-fM sample.
We also studied in situ padlock/RCA using cultured cells, in which a microchannel with a dam was constructed to trap cells. 23 The channel selectively captured breast cancer cells and amplification by in situ padlock/RCA of the cancer marker HER2 could be achieved in a microspace; however, since the main purpose of the study was cell trapping, technical aspects of this method, such as differences in performance between a microfluidic device and a conventional well were not investigated.
In the present study, we developed an automated microfluidic system for in situ padlock/RCA that reduces the cost and manual operation involved. Although attempts have been made to reduce the reagents used in microfluidic in situ DNA analysis by FISH [16] [17] [18] and an automated microfluidic system for FISH has been developed, 17 this is the first report of an automated microfluidic system for in situ padlock/RCA.
In the conventional static method, there is no flow of reaction solution, and microfluidic conditions can potentially affect the reaction efficiency. Hence, in this study, the reaction conditions in an automated microfluidic system were investigated. In addition, the in situ padlock/RCA was used to detect three mitochondrial DNA fragments in a microchannel under optimized conditions.
Experimental

Device fabrication
Instead of the SecureSeal system (Grace Bio-Lab, Bend, OR) that is typically used, 5, 10, 11 in this study, wells consisted of a cover slip and a 2-mm thick polydimethylsiloxane (PDMS) sheet (Silpot 184 W/C; Dow Corning Toray Co., Ltd., Tokyo, Japan) punched with a 5-mm inner diameter (i.d.) hole (Fig. 1a) .
The microfluidic devices were fabricated as previously reported, 24 with minor modifications (Fig. 1b) . Briefly, a PDMS sheet with a recessed microchannel pattern (width × depth × length, 1 mm × 200 μm × 10 mm) was fabricated by replica molding using an acrylic resin sheet mold. The 4-mm thick PDMS sheet was cured and peeled off, then bonded to a cover slip after plasma treatment. Holes were made through both ends of the sheet with a 1-mm biopsy punch (Kai Industries, Seki, Japan) or a 23G syringe blunt needle (Nipro Corp., Tokyo, Japan). A polytetrafluoroethylene ( 
Micro-padlock/RCA system
The automated micro-padlock/RCA system (width × length × height, 275 × 245 × 300 mm) was constructed by the Institute of Microchemical Technology (Kawasaki, Japan), based on the previously reported micro-enzyme-linked immunosorbent assay system (Fig. 2) . 25 The microfluidic device was set on a Peltier temperature controller that controlled the reaction temperature. A 250-μL syringe pump was used for the infusion. The suction/ discharge speed was in the range of 1 -800 μL/min, and the injector driving speed was 50 -800 mm/min. The automated rotating stage (carousel) had 16 positions to hold PCR tubes and one for a 1-mL tube. Padlock/RCA was controlled by the μFlowSystem software (Institute of Microchemical Technology).
The PEEK tubes of the device were connected to injection and waste ports of the system via Teflon connectors. The washing buffer was used as a carrier solution. Reagents were stocked in PCR tubes on the carousel, and the PEEK tube injector aspirated a specified volume of reagent (5 -60 μL) under the control of a syringe pump. The injector was connected to the device through the injection port, i.e., a Teflon connector and two PEEK tubes, one from the injection port to the Teflon connector, and the other from the Teflon connector to the microfluidic device, which had lengths of 20 and 5 cm, respectively. The reagents and washing buffer were pumped into the microchannel at 30 μL/min with the syringe pump. 
Cell culture in the microchannel and well
HeLa cell suspensions (RIKEN Cell Bank, Tsukuba, Japan) were prepared at densities of 1.5 -2.0 × 10 3 cells/μL and 100 cells/μL, and introduced into the microchannel or well, respectively, which were manually precoated with 1 mg/mL Matrigel (BD Bioscience, San Jose, CA). The devices were humidified by wrapping with a wet, lint-free wiper and plastic wrap, then incubated at 37 C and 5% CO2 for 16 h to allow cells to adhere to the bottom of the channel or well.
Padlock/RCA
Padlock/RCA was performed as previously described, 4 with minor modifications to adapt the procedure to the microchannel format. The reaction solutions (5 -60 μL) were injected into the microRCA system, and reactions were performed under stopped-flow conditions.
HeLa cells were fixed with 20 μL of 70% EtOH for 20 min, washed with 60 μL Tris-HCl (0.1 M Tris-HCl, 0.15 M NaCl, and 0.05% Tween-20, pH 7.4) or Tris-acetate (20 mM Trisacetate, 10 mM Mg(CH3COO)2, 50 mM CH3COOK, 1 mM dithiothreitol, and 0.05% Tween-20, pH 7.9) washing buffer at 25 C, then treated with 20 μL of 0.01% pepsin in 0.1 M HCl for 90 s at 37 C, followed by a wash with 60 μL of Tris-HCl or Tris-acetate washing buffer.
The reactions were performed in 5 -30 μL solution and 60 μL washing buffer. Target sequences were made accessible to hybridization by digestion with 0.5 U/μL MscI restriction enzyme and 0.4 U/μL T7 exonuclease (both from New England Biolabs, Ipswich, MA) at 37 C for 40 min in 1× restriction enzyme buffer supplemented with 0.2 mg/mL bovine serum albumin (BSA; New England Biolabs). The microchannel was washed with Tris-HCl or Tris-acetate washing buffer at 25 C.
Mitochondrial DNA-specific padlock probes were purchased from Sigma-Aldrich Japan (Hokkaido, Japan). The sequences were as follows: ppMSCs (2993-bp fragment), 4 5′- P-TAA GAA  GAG GAA TTG CCT TTC CTA CGA CCT CAA TGC ACA  TGT TTG GCT CCT CTT CCC ATG GGT ATG TTG T-3′;  ppMSC952 (952-bp fragment), 5′-P-TAG ATA GTT GGG TGG  CTT TTC CTA CGA CCT CAA TGC ACA TGT TTG GCT  CCT CTT CCC ATG GCA GGT TTA-3′; and ppMSC4037 (4037-bp fragment), 5′-P-TAA GGG AGG GAT CGT CCT TTC CTA CGA CCT CAA TGC ACA TGT TTG GCT CCT CTT CCA ATT TGA TGG-3′. Probe hybridization and ligation were performed in a single reaction with 100 nM probe and 0.1 U/μL T4 DNA ligase (Fermentas, Hanover, MD) in 1× T4 ligase buffer, 0.2 mg/mL BSA, and 250 mM NaCl at 37 C for 30 min; the microchannel was then washed with Tris-HCl or Tris-acetate washing buffer at 25 C.
The RCA reaction was performed with 1 U/μL phi29 DNA polymerase (New England Biolabs), 0.25 mM dNTP, 0.2 mg/mL BSA, and 5% glycerol in 1× phi29 polymerase buffer at 30 C for 1.5 h. After polymerization, the microchannel was washed with washing buffer at 25 C. The single-stranded RCA products were detected by hybridization with 250 nM Lin33 fluorescently labeled oligonucleotide probe (5′-Alexa555-CCT CAA TGC ACA TGT TTG GCT CC-3′ 4; Operon Biotechnologies, Tokyo, Japan) in a solution of 2× saline-sodium citrate and 8% formamide for 20 min at 37 C. Cell nuclei were stained with 10 μg/mL Hoechst 33342 at 25 C.
Image analysis
Samples were visualized with an IX 71 fluorescence microscope (Olympus, Tokyo, Japan) with a PlanApo 60× oil immersion objective lens and Chroma 86009 BFP/GFP and DsRed filter set, with 380/450 nm and 555/620 nm excitation/ emission for Hoechst 33342 and Alexa 555, respectively. Images were acquired with a Cascade 512F charge-coupled device camera (Photometrics, Tucson, AZ or DP30BW, Olympus) and processed using MetaMorph (Molecular Devices, Sunnyvale, CA) or DP controller (Olympus) software.
Results and Discussion
Micro-padlock/RCA system
The automated micro-padlock/RCA system was evaluated in terms of reagent injection and temperature control. The protocol has six steps: (1) cell fixation, (2) pepsin treatment, (3) enzymatic target preparation, (4) padlock probe hybridization and ligation, (5) RCA, and (6) fluorescence-labeled probe hybridization. A total of 13 solution changes, including washing steps, are required for the conventional method. In contrast, the automated system employs a carousel that can accommodate 16 different solutions and the washing buffer, which was used as a carrier solution, and the temperature of the reactions (25 -37 C) was controlled by a Peltier-based system.
The progressive dilution of the reaction solution resulting from sequential reagent injection is a major problem in microfluidic analyses; the relationship between injection volume and dilution of the reaction solution was therefore examined. A 10-μM fluorescein isothiocyanate-labeled BSA solution was injected into the microchannel prefilled with washing buffer. The injected fluorescent solution was not significantly diluted with the washing buffer when the injected volume was > 30 μL (Fig. 3) .
Optimization of washing buffer
When 20 μL of reaction solution was added to the microchannel, the reaction efficiency was lower than that obtained with the well, as evidenced by the lower number of amplification products (9.7 ± 4.6 vs. 60 ± 17). We hypothesized that the reaction rate in the microchannel was decreased by the dilution of the reaction solutions with the washing buffer at the liquid/liquid interface. To investigate the effect of dilution on reaction efficiency, the amplification was performed in the wells using diluted reagents.
First, the concentration of each enzyme, padlock probe, or dNTP was reduced to 40% of the normal reaction conditions. All reactions were performed with the optimal buffer supplied with each enzyme. As shown in Fig. 4 , the number of the reaction products obtained under each condition was similar to that of the control experiment. Therefore, we concluded that the dilution of the reaction solutions has little effect on the reaction rates.
Next, each reaction solution was diluted with the washing buffer. As shown in Fig. 5 , the first step reaction was inhibited with the Tris-HCl washing buffer, which inhibited the first step (i.e., MscI and exonuclease digestion). Enzymatic activity is reduced to 75% (MscI) and 1% (exonuclease) in Tris-HCl according to the manufacturer. Tris-acetate did not affect the reactions and was used as the washing buffer in subsequent experiments. Therefore, washing buffer selection was important when using microchannels but not wells, since solutions in the well were completely removed by aspiration.
Mitochondrial DNA amplification using the micro-padlock/RCA system
The performance of the micro-padlock/RCA system was investigated under optimal buffer conditions. Since the process was automated, only reagent preparation and handling steps were required. The entire process required about 3 h, 40 min for enzymatic target preparation, 30 min for padlock probe hybridization and ligation, 90 min for RCA, and 20 min for fluorescence-labeled probe hybridization, with short washing steps between reactions.
The relationship between the injected volume of each reagent and the number of amplified products was examined. When the volume was ≥ 10 μL, the reaction efficiency was unaffected by dilution (Fig. 6 ). In addition, 49.7 ± 22.4, 44.9 ± 10.4, and 30.0 ± 9.0 products corresponding to 952-, 2993-, and 4037-bp fragments of mitochondrial DNA, respectively, were detected under optimal conditions from 15 pictures (Fig. 7) . The number of products obtained by the micro-padlock/RCA system and Step 1, enzymatic target preparation; step 2, padlock probe hybridization and ligation; step 3, RCA. The reaction solution of the specified reaction step was mixed with the washing buffer in a 4:6 ratio. Tris-HCl buffer (stripe) hindered the first step, i.e., restriction enzyme and exonuclease digestion. Tris-acetate buffer (black) did not affect the reactions. Data are shown as mean ± 1 SD (n = 15). *P < 0.05 (unpaired two-tailed Student's t-test). ▨. Tris-HCl, . Tris-acetate. Fig. 6 Relationship between injected volume of each reagent and number of amplification products. Fig. 4 Effect of enzyme or probe concentration on the number of detected RCA products. The concentration of the specified reagent was reduced to 40% that of normal conditions. The number of signals per cell was digitally counted using Image J software (National Institutes of Health, Bethesda, MD). Data are shown as mean ± 1 SD of from 15 pictures.
well format was similar (data not shown). The possibility that small DNA fragments were washed out under flow conditions in the microchannel, which would decrease the number of RCA products detected, cannot be excluded; however, the flow washing process (30 μL/min) had no effect on the efficiency with which the 952-bp fragment was detected.
Conclusions
In this study, specific DNA fragments were detected by in situ padlock/RCA using a simplified, automated microfluidic system. After reaction solution volumes and washing buffer composition were optimized, amplification product yields were equal to those obtained using the conventional manual method. Moreover, the required volume of reagents was reduced to 10 μL, which is less than half the volume used in the conventional method. The in situ padlock/RCA method can be useful as an adjunctive technique in the diagnosis of diseases, for instance in determining the efficacy of drugs targeting specific molecules in cancer therapy.
